Eramo A - Search Results

1

Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells.

Sette G, Salvati V, Giordani I, Pilozzi E, Quacquarini D, Duranti E, De Nicola F, Pallocca M, Fanciulli M, Falchi M, Pallini R, De Maria R, Eramo A. Sette G, et al. Among authors: eramo a. Int J Cancer. 2018 Jul 1;143(1):88-99. doi: 10.1002/ijc.31260. Epub 2018 Jan 26. Int J Cancer. 2018. PMID: 29341112

2

Caspase activation without death.

Zeuner A, Eramo A, Peschle C, De Maria R. Zeuner A, et al. Among authors: eramo a. Cell Death Differ. 1999 Nov;6(11):1075-80. doi: 10.1038/sj.cdd.4400596. Cell Death Differ. 1999. PMID: 10578176 Review.

3

Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1.

Zeuner A, Eramo A, Testa U, Felli N, Pelosi E, Mariani G, Srinivasula SM, Alnemri ES, Condorelli G, Peschle C, De Maria R. Zeuner A, et al. Among authors: eramo a. Cell Death Differ. 2003 Aug;10(8):905-13. doi: 10.1038/sj.cdd.4401255. Cell Death Differ. 2003. PMID: 12867998

4

CD95 death-inducing signaling complex formation and internalization occur in lipid rafts of type I and type II cells.

Eramo A, Sargiacomo M, Ricci-Vitiani L, Todaro M, Stassi G, Messina CG, Parolini I, Lotti F, Sette G, Peschle C, De Maria R. Eramo A, et al. Eur J Immunol. 2004 Jul;34(7):1930-40. doi: 10.1002/eji.200324786. Eur J Immunol. 2004. PMID: 15214041 Free article.

5

Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction.

Eramo A, Pallini R, Lotti F, Sette G, Patti M, Bartucci M, Ricci-Vitiani L, Signore M, Stassi G, Larocca LM, Crinò L, Peschle C, De Maria R. Eramo A, et al. Cancer Res. 2005 Dec 15;65(24):11469-77. doi: 10.1158/0008-5472.CAN-05-1724. Cancer Res. 2005. PMID: 16357155

6

Chemotherapy resistance of glioblastoma stem cells.

Eramo A, Ricci-Vitiani L, Zeuner A, Pallini R, Lotti F, Sette G, Pilozzi E, Larocca LM, Peschle C, De Maria R. Eramo A, et al. Cell Death Differ. 2006 Jul;13(7):1238-41. doi: 10.1038/sj.cdd.4401872. Epub 2006 Feb 3. Cell Death Differ. 2006. PMID: 16456578 No abstract available.

7

Identification and expansion of the tumorigenic lung cancer stem cell population.

Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R. Eramo A, et al. Cell Death Differ. 2008 Mar;15(3):504-14. doi: 10.1038/sj.cdd.4402283. Epub 2007 Nov 30. Cell Death Differ. 2008. PMID: 18049477

8

Lung cancer stem cells: tools and targets to fight lung cancer.

Eramo A, Haas TL, De Maria R. Eramo A, et al. Oncogene. 2010 Aug 19;29(33):4625-35. doi: 10.1038/onc.2010.207. Epub 2010 Jun 7. Oncogene. 2010. PMID: 20531299 Review.

9

Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma.

Tafani M, Di Vito M, Frati A, Pellegrini L, De Santis E, Sette G, Eramo A, Sale P, Mari E, Santoro A, Raco A, Salvati M, De Maria R, Russo MA. Tafani M, et al. Among authors: eramo a. J Neuroinflammation. 2011 Apr 13;8:32. doi: 10.1186/1742-2094-8-32. J Neuroinflammation. 2011. PMID: 21489226 Free PMC article.

10

Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy.

Bartucci M, Svensson S, Romania P, Dattilo R, Patrizii M, Signore M, Navarra S, Lotti F, Biffoni M, Pilozzi E, Duranti E, Martinelli S, Rinaldo C, Zeuner A, Maugeri-Saccà M, Eramo A, De Maria R. Bartucci M, et al. Among authors: eramo a. Cell Death Differ. 2012 May;19(5):768-78. doi: 10.1038/cdd.2011.170. Epub 2011 Nov 25. Cell Death Differ. 2012. PMID: 22117197 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters